Leucovorin: all 351 studies that test it
Page 2 of 4. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic CancerCompletedNCT01494506Phase 3Results posted
- FOLFIRINOX in Patients With Inoperable Pancreatic CancerTerminatedNCT01359007Phase 2Results posted
- PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination ChemotherapyCompletedNCT01333033Phase 2Results posted
- Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction CancerTerminatedNCT01307956Phase 2Results posted
- First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With RegorafenibCompletedNCT01289821Phase 2Results posted
- Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01280643Not applicableResults posted
- A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.CompletedNCT01227707Phase 2Results posted
- Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic LymphomaCompletedNCT01190930Phase 3Results posted
- A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and AvastinCompletedNCT01077739Phase 2Results posted
- Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal CancerCompletedNCT01060007Phase 2Results posted
- Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus TumorsTerminatedNCT01014767Phase 3Results posted
- Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell TumorsCompletedNCT00957905Phase 2Results posted
- Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous TreatmentCompletedNCT00942266Phase 2Results posted
- Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell LymphomaCompletedNCT00878254Phase 2Results posted
- Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous SystemCompletedNCT00653068Phase 3Results posted
- Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without VoraxazeCompletedNCT00634504Phase 1Results posted
- Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System LymphomaCompletedNCT00594815Not applicableResults posted
- Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck CancerCompletedNCT00544414Phase 2Results posted
- Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)CompletedNCT00525785Phase 2Results posted
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaCompletedNCT00515411Phase 2Results posted
- Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) TumorsCompletedNCT00515216Phase 2Results posted
- Folfox-B Study for Patients With Colorectal Liver MetastasesTerminatedNCT00508872Phase 2Results posted
- R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell LymphomaCompletedNCT00450801Phase 2Results posted
- Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal CancerTerminatedNCT00449163Phase 2Results posted
- Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By SurgeryCompletedNCT00448760Phase 2Results posted
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By SurgeryTerminatedNCT00448682Phase 2Results posted
- Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaCompletedNCT00390416Phase 2Results posted
- Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer PatientsCompletedNCT00354978Phase 2Results posted
- Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By SurgeryCompletedNCT00321828Phase 2Results posted
- Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal CancerCompletedNCT00321685Phase 2Results posted
- Chemotherapy and HAART to Treat AIDS-related Primary Brain LymphomaCompletedNCT00267865Phase 2Results posted
- Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerCompletedNCT00217737Phase 3Results posted
- Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal CancerCompletedNCT00199797Phase 1Results posted
- Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal CancerCompletedNCT00193219Phase 2Results posted
- Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal CancerCompletedNCT00143403Phase 3Results posted
- Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal CancerCompletedNCT00111761Phase 2Results posted
- S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00109837Phase 2Results posted
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesCompletedNCT00096135Not applicableResults posted
- Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RTCompletedNCT00084838Phase 2Results posted
- Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaCompletedNCT00075725Phase 3Results posted
- Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic LymphomaCompletedNCT00004228Phase 3Results posted
- Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric CancerCompletedNCT00003298Phase 2Results posted
- Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically RemovedTerminatedNCT00002525Phase 3Results posted
- A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric AdenocarcinomaActive, not recruitingNCT07257575Phase 2
- Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and BevacizumabActive, not recruitingNCT06107413Phase 2
- NEO-adjuvant Chemo-immunotherapy in Pancreatic CancerActive, not recruitingNCT06094140Phase 2
- Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction AdenocarcinomaActive, not recruitingNCT05715931Phase 2
- Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical SurgeryActive, not recruitingNCT05713838Phase 2
- Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric AdenocarcinomaCompletedNCT05504720Phase 2
- A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract MalignanciesActive, not recruitingNCT05329766Phase 2
- Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric CancersWithdrawnNCT05296005Phase 1
- Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29Active, not recruitingNCT05253846Phase 2
- FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal CancerStatus unknownNCT05018182Phase 2
- Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum DisorderCompletedNCT05013164Phase 2
- Perioperative Chemotherapy in Gastric CancerTerminatedNCT04937738Phase 2
- Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic CancerActive, not recruitingNCT04927780Phase 3
- No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal CancerCompletedNCT04864067Phase 2
- Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT04752696Phase 2
- Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric CancerCompletedNCT04354662Phase 2
- Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic CancerActive, not recruitingNCT04340141Phase 3
- Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the BodyActive, not recruitingNCT04248452Phase 3
- Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has SpreadActive, not recruitingNCT04233866Phase 2
- PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric CancerStatus unknownNCT04174339Not applicable
- POF Versus FOLFOX Plus IP Paclitaxel in AGCStatus unknownNCT04155671Phase 2
- Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS MutationTerminatedNCT04034173Phase 2
- NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary CancerActive, not recruitingNCT04005339Phase 2
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine CarcinomaCompletedNCT03837977Phase 2
- PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT03791905Phase 2
- A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric CancerStatus unknownNCT03788226Phase 3
- Apatinib Combined With POF for Second-line Treatment of Gastric AdenocarcinomaStatus unknownNCT03788174Phase 2
- FOLFIRINOX for 2nd-line Treatment of BTCCompletedNCT03778593Phase 2
- Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACEWithdrawnNCT03722498Phase 2
- Study of the Combination of Apatinib and POFStatus unknownNCT03707639Phase 2
- Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerStatus unknownNCT03703063Phase 1
- Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric CancerCompletedNCT03647969Phase 2
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesStatus unknownNCT03607643Phase 1/2
- mFLOT Chemotherapy as First-line Treatment in GCCompletedNCT03606928Phase 1/2
- QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) VaccineWithdrawnNCT03563170Phase 1/2
- QUILT-3.088: NANT Pancreatic Cancer VaccineWithdrawnNCT03563144Phase 2
- Locally Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT03559348Phase 2
- QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) VaccineWithdrawnNCT03554109Phase 2
- TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRCCompletedNCT03517618Phase 2
- mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First LineCompletedNCT03464968Phase 2
- SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic CancerCompletedNCT03443492Phase 2
- Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT03406299Phase 2
- Phase I Study of the Combination of Apatinib and POFStatus unknownNCT03244774Phase 1
- QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) TherapyWithdrawnNCT03197584Phase 1/2
- QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03197571Phase 1/2
- QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyWithdrawnNCT03175666Phase 1/2
- QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLWithdrawnNCT03169790Phase 1/2
- QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRCWithdrawnNCT03169777Phase 1/2
- QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03169764Phase 1/2
- QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsWithdrawnNCT03169738Phase 1/2
- QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03167177Phase 1/2
- QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 TherapyWithdrawnNCT03167164Phase 1/2
- A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic CancerStatus unknownNCT03167112Phase 2
- Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy NetworkCompletedNCT03164655Phase 2
- Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric CancerCompletedNCT03121807Not applicable
- FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective StudyWithdrawnNCT03110510Phase 2